With the rate of new HIV infections at just under 40,000 new infections per year, it is important for addiction practitioners to be on the front lines of HIV prevention. This article and corresponding table cover the pre-exposure prophylaxis (PrEP) with Truvada.

For patients on buprenorphine maintenance facing surgery, it is crucial to balance the need to minimize pain while addressing the risk of relapse. In this interview, Dr. Gregory Acampora guides us through the specifics on perioperatively managing patients on varying doses of buprenorphine maintenance.

Prolonged exposure is one of the best treatments available for patients with PTSD. This study examines the advantages of using prolonged exposure for patients who have PTSD with co-occurring alcohol use disorder.

This research update unpacks the details behind the landmark “EAGLES” trial (Evaluating Adverse Events in a Global Smoking Cessation Study), which led to the removal of the varenicline black box warning.

This research update summarizes the results of the landmark COMBINE study which evaluated the effectiveness of stand-alone and combined pharmacological and behavioral interventions for treating alcohol use disorder.

Teen suicidality is rising and child psychiatrists need support in knowing how to address suicidality in everyday practice. In this lead article we discuss office assessment, treatment, planning, and prevention for at risk children and teens. For reference we also include the Ask Suicide-Screening Questions Toolkit Questionnaire as well as a table presenting some of the evidence-based approaches for suicide screening.

Psychosocial interventions for substance use disorders include drug counseling, medical management, cognitive behavioral therapy, motivational interviewing, contingency management, the community reinforcement approach, and twelve-step facilitation

The newer biomarkers of alcohol use include carbohydrate-deficient transferrin; ethyl glucuronide and ethyl sulfate; and phosphatidylethanol.

N-acetylcysteine (NAC), an over-the counter supplement related to the amino acid cysteine, has been shown to have some efficacy in adolescents with cannabis use disorder (CUD). This current study explores whether NAC can be effective for CUD in adult patients as well.

Addiction is stigmatized, resulting in historically strict confidentiality rules. But how do we interpret HIPAA and other regulations in 2019 addiction practice? Do we need a ROI every time we communicate with other clinicians/institutions, which seems cumbersome and counterproductive? In this article we cover what you need to know about confidentiality in addiction treatment.